H1 2009 AstraZeneca PLC Earnings Conference Call  Today's Calls

Visit the TF Network Sites· Corporate IR Center · Institutional Investor Center · Individual Investor Center Download Plug-In Real Player 8 Basic Windows Media Player Other Conference Calls Other Jul 30 Calls Today's Calls

Call Details H1 2009 AstraZeneca PLC Earnings Conference Call Thu, Jul 30, 2009, 8:00 am Eastern Listen to the archived event audio About AstraZeneca PLC (NYSE:AZN) AstraZeneca plc discovers, develops, manufactures, and markets prescription pharmaceuticals and biological products in the areas of cardiovascular, gastrointestinal, neuroscience, oncology, respiratory and inflammation, and infection worldwide. Its primary products include Arimidex for hormonal breast cancer; Crestor that provides treatment for managing cholesterol levels; Nexium for acid-related diseases; Seroquel, an atypical anti-psychotic therapy for treating schizophrenia and bipolar mania; and Symbicort for the treatment of asthma in patients. The company also engages in the research, development, manufacture, and marketing of medical devices and implants for use in urology, surgery, and odontology. In addition, it develops and manages hospital-based outpatient cancer centers in the United States; and produces individually adapted abutments for dental implants using a patented CAD/CAM method. The company markets its products to primary care and specialist physicians, as well as to other healthcare professionals, governments, and healthcare buying groups through sales and marketing network, local marketing companies, distributors, and local representative offices. It has collaboration agreements with Bristol-Myers Squibb Company; POZEN Inc.; Abbott laboratories; Columbia University and Newcastle University; Palatin Technologies, Inc; BioDuro Inc.; Jubilant Organosys Ltd.; Merck & Co. Inc.; Cancer Research Technology Limited; Institute of Cancer Research; Alcon Inc.; and Mental Health Research Institute. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca plc in April 1999. AstraZeneca plc was founded in 1992 and is headquartered in London, the United Kingdom. More Info: Quote | Chart | Profile | Reports | Research | Msgs | Financials